Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gradual deterioration of cognitive functions in Alzheimer's disease is paralleled by a hierarchical progression of amyloid-beta and tau brain pathology. Recent findings indicate that toxic oligomers of amyloid-beta may cause propagation of pathology in a prion-like manner, although the underlying mechanisms are incompletely understood. Here we show that small extracellular vesicles, exosomes, from Alzheimer patients' brains contain increased levels of amyloid-beta oligomers and can act as vehicles for the neuron-to-neuron transfer of such toxic species in recipient neurons in culture. Moreover, blocking the formation, secretion or uptake of exosomes was found to reduce both the spread of oligomers and the related toxicity. Taken together, our results imply that exosomes are centrally involved in Alzheimer's disease and that they could serve as targets for development of new diagnostic and therapeutic principles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, in damaged environments, like AD, exosomes are involved in the transportation of damaging proteins like Aβ and Tau [116].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [116]
The cited source says what the claim attributes to it.
In the citing paper
“A previous study has shown that sEVs isolated from the brains of AD patients contain elevated levels of Aβ oligomers [141].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“These EVs have been discovered as possible transporters for transferring toxic protein species from neuron to neuron, as has been shown in vitro.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“oAβ42 has been detected within neuronal exosomes.”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Data from cells treated with these exosomes also revealed that the exosomes facilitated delivery of oAβ42 and induced toxic effects [24].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200 · cited 1×
“These findings suggest that exosomes might be the main mediator of the pathogenic progression in AD as was recently suggested for dementia with Lewy bodies [41].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 2×
“It has been suggested that exosomal release may provide an alternative disposal mechanism to lysosomal degradation of oAβ [5] or other proteins that are resistant to degradation [55].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The nature of the propagating species has not been established, although several studies have indicated a particularly pathogenic role of soluble oAβ on synaptic and cellular functions and structure [13, 32, 50, 60].”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“1 3 Aß, tau and α-synuclein [12, 17, 46, 59] and can propagate tau pathology [4].”
BackgroundAlzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 2×
“Accordingly, exosomes from blood [22], CSF [17, 49] and cell cultures [46] have been shown to contain monomeric Aβ and tau, but so far, no study has addressed the presence of oAβ in exosomes from human AD brains.”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 1×
“Here dystrophic neurites with neurite beading and loss of neurite branching were identified, known early signs of neurodegeneration [51].”
Background
Research works printed but not linked: 1
- Tucker S, Möller C, Tegerstedt K, Lord A, Laudon H, Sjödahl J, Söderberg L, Spens E, Sahlin C, Waara ER et al (2015) The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. JAD 43:575–588. https://doi.org/10.3233/JAD-140741 · DOI · Paper page
Cited by
Items 501–530 of 530
Zhou, A. (2024) · theses.fr (ABES) · doi:10.70675/6309815dzcc1az48bdz829az59d3407d7a4f · Cited by 1
Célestine, M. (2023) · theses.fr (ABES) · doi:10.70675/873ca377z9a97z43f6z8051zdab4082686ba · Cited by 1
Ribeiro, L. W. (2023) · theses.fr (ABES) · doi:10.70675/68582d99z4406z4ad4zbd76z15927fb63da5
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
goff, M. L. (2020) · theses.fr (ABES) · doi:10.70675/abe2211bz153az4cedzbd39zd246c92ed5bb · Cited by 1
川上, 惇., & Kawakami, S. (2026) · Institutional Repositories DataBase (IRDB)
Exosomes in Amyloid Propagation—Roles in Neurodegeneration
Mishra, R., & Upadhyay, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05913-w
Balistreri, A., Turner, N., Compher, J., Almaraz, M., Prabhavalkar, A., Chittal, S., Labra, S. R., Ezekiel, K., Baal, C., Kwong, C. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.724352
“Cerebrocortical organoids offer several advantages as an EV source for studying AD compared with previously used sources like blood plasma, CSF, or postmortem brain homogenates (Wang et al. 2017; Fiandaca et al. 2015; Sardar Sinha et al. 2018).”
D´Arrigo, D., Park, K., Lässer, C., Sigalas, G. P., Symonds, E., Urzì, O., Locatelli, C., Bagge, R. O., Lötvall, J. O., & Crescitelli, R. (2026) · BMC Medicine · doi:10.1186/s12916-026-04923-8
Lopez, J. (2025) · PDXScholar (Portland State University) · doi:10.15760/honors.1795
Glycolysis: The Bridge Between Cellular Interaction and Alzheimer’s Disease
Lei, Q., He, Y., & Fang, B. (2026) · Biomolecules · doi:10.3390/biom16060796
“Aggregates of Tau and A β proteins can be transported by exosomes from neurons to nearby microglia [176,177].”
Tiny Messengers, Big Impact: The Role of Endogenous Extracellular Vesicles in Neurological Diseases
Alzamora, L., Lin, Z., Li, W., & Lo, E. H. (2026) · Current Neuropharmacology · doi:10.2174/011570159x387438250823212133 · Cited by 1
Sato, A., & Ito, E. (2026) · World Journal of Methodology · doi:10.5662/wjm.120686
Extracellular Vesicles in Stroke: Drivers of Brain–Body Network Crosstalk
Xu, Z. Y., Yu-Jia, J., Zhang, W., Ye, X.-H., & Gao, F. (2026) · Translational Stroke Research · doi:10.1007/s12975-026-01452-7
“Supporting a propagation mechanism, small EVs/exosomes can harbor seeding-competent Aβ species and facilitate intercellular spread of amyloid pathology [41].”
3D nanoscale imaging of amyloid-β oligomer interactions with extracellular vesicles by cryo-ET
Khursheed, A., Shang, Q., Zhang, H., Tian, Y., Szwedziak, P., Volkov, V. A., & Viles, J. H. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2610068123
Liquid crystal biosensing platform based on whispering gallery mode laser for Aβ42 detection
An, P., Li, M., Zhang, S., Lian, D., Li, C., Wang, C., Yu, M., Wang, D., Kong, L., Ren, J., et al. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115985
Glial vesicular signaling and Alzheimer’s disease progression
Yadav, K., Sonwani, S., Bana, K., & Tiwari, S. S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.07.010
Exosome-Mediated Systemic Signaling: Mechanisms, Disease Integration, and Translational Potential
Madore, A., Walsh, N., Desai, K., Udoh, G., Gannavaram, N. L., Kandula, A., Yates, C., Pillai, S. S., Sodhi, K., & Gonçalves, B. D. S. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080845
Extracellular vesicles in neurodegenerative diseases: A new frontier in diagnosis and therapy
Mohammad, S. I., Vasudevan, A., Oriquat, G., Gajjar, T. B., Hanumanthayya, M., Shukla, S. K., Tailor, N. K., Baig, M. R., Fadaam, O., & Abdul, A. S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116455
Extracellular vesicles in Alzheimer’s disease: New perspectives on diagnosis and therapy
Klepe, A., Mi, J., Neuhaus, W., & Burek, M. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.024
AYDIN, A. C. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06191-2
Exosomes: The Elixir or the Trojan Horse
Khosravipour, A., Mansoori, M., Aboutalebi, H., Hashemi, F., & Vafaei, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119957
Qin, Q., Yan, Q., Zhu, K., Miao, J., Yang, M., Wu, Z., Fan, C., Jiang, P., Wu, G., & Wang, Q. (2026) · Molecules · doi:10.3390/molecules31203681
“Thus, inhibiting exosome formation, secretion, and uptake has been shown to effectively reduce the transport of oligomers and their associated toxicities [120].”
Jacquier‐Sarlin, M. R., Seignobos, M., Rauzier, L., Schaack, B., Laurin, D., & Buisson, A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1963040
“EV-associated pathological proteins may display enhanced seeding activity, promoting the propagation of protein misfolding between neighbouring and distant cells (Guo and Lee, 2014; Sardar Sinha et al., 2018; Brunello et al., 2020).”
Exosome-amyloid interplay: Mechanisms, pathological roles, and materials-driven opportunities
Nazari, M., & Rabiee, N. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.116274
Murthy, M. K. (2026) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2026.127984
Metadata
- Authors
- Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Uppsala University (SE)
- Corresponding author
- Hallbeck, Martin
- Venue
- Acta Neuropathologica
- Published
- 2018-06-13
- Volume
- 136
- Issue
- 1
- Pages
- 41-56
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6015111
- OpenAlex
- W2807776100
- Cited by
- 527
- References
- 60
- Citations by year
- 2026: 48 · 2025: 70 · 2024: 71 · 2023: 64 · 2022: 60 · 2021: 74 · 2020: 82 · 2019: 50 · 2018: 6
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Funders
- Vetenskapsrådet (523-2013-2735)
- Alzheimerfonden
- Hjärnfonden
- Hans-Gabriel och Alice Trolle Wachtmeister Stiftelse för Medicinsk forskning
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Knut och Alice Wallenbergs Stiftelse
- Demensförbundet
- Linköpings Universitet
- Region Östergötland
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, exosomes, amyloid-beta oligomers, prion-like propagation, extracellular vesicles, tau pathology, exosome secretion, exosome uptake, neurotoxicity
- MeSH terms
- Tsg101 Protein, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cell Line, Transformed, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, L-Lactate Dehydrogenase, Male, Membrane Proteins, Middle Aged, Neuroblastoma, Organic Chemicals, Peptide Fragments, Transcription Factors, Amyloid beta-Peptides, Culture Media, Conditioned, Coculture Techniques, Protein Transport, Pluripotent Stem Cells, Microscopy, Electron, Transmission, Exosomes, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.